Recurrent Endometrial Cancer Not Yet Recruiting Phase 1 / 2 Trials for Metformin (DB00331)

Also known as: Endometrial cancer recurrent / Cancer of endometrium recurrent / Ca endometrium recurrent / Endometrial carcinoma recurrent / Carcinoma endometrial recurrent

IndicationStatusPhase
DBCOND0054384 (Recurrent Endometrial Cancer)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02755844Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsTreatment